RESEARCH NEWS

Results of study conducted at CRI show early HIV 

treatment saves lives

 


Thanks to you, CRI participated in an innovative study, the results of which were just released. The START (Strategic Timing of Antiretroviral Treatment) study results show that people with HIV should start antiretroviral (ARV) therapy as soon as possible after diagnosis to avoid developing AIDS and other serious illnesses.

START is the first major randomized clinical trial to produce definitive evidence that HIV-positive people who start treatment immediately after diagnosis will be healthier and live longer. The results may lead to a change in the treatment guidelines recommended by the World Health Organization, and aid in preventing new infections worldwide.
 

"In addition to showing that HIV-positive people who start ARV treatment early will live longer, healthier lives, the results of this study have the potential to influence treatment policy and help with international prevention efforts. By lowering people's viral loads as soon as possible after diagnosis, we can prevent more new infections." --Dr. Hannah Bouldin Olivet, CRI's Associate Research Director and Principal Investigator of HIV Studies

In light of these findings, study participants worldwide will be notified of the results and will be offered treatment if they are not already on ARV therapy. The study will continue to gather follow-up data through 2016. 

These important findings are the collective effort of hundreds of research staff, thousands of study participants, and you--because your support makes CRI's research possible. Thank you.

 

Further details on the results of the START study are available for you to read in

CRI's press release, the National Institute of Health press release, and The New York Times
 

For more information about clinical trials at CRI, visit us online or call 617.502.1700.
Community Research Initiative (CRI) is an independent, nonprofit, community-based organization in New England dedicated to HIV and hepatitis C clinical research, treatment education, and financial assistance for approved drug treatments and health insurance coverage.

For more information about CRI and how you can be involved, visit www.crine.org.

CONNECT WITH YOUR COMMUNITY

Like us on Facebook    Follow us on Twitter    View our videos on YouTube